Chemoinformaics analysis of (Z,Z)-Heptadeca-1,8,11-triene
| Molecular Weight | 234.427 | nRot | 12 |
| Heavy Atom Molecular Weight | 204.187 | nRig | 3 |
| Exact Molecular Weight | 234.235 | nRing | 0 |
| Solubility: LogS | -3.458 | nHRing | 0 |
| Solubility: LogP | 5.533 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 47 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 48.3938 |
| nHD | 0 | BPOL | 30.0962 |
| QED | 0.278 |
| Synth | 2.495 |
| Natural Product Likeliness | 1.323 |
| NR-PPAR-gamma | 0.343 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.02 |
| CACO-2 | -4.856 |
| MDCK | 0.0000379 |
| BBB | 0.651 |
| PPB | 0.992545 |
| VDSS | 3.271 |
| FU | 0.0066265 |
| CYP1A2-inh | 0.583 |
| CYP1A2-sub | 0.524 |
| CYP2c19-inh | 0.533 |
| CYP2c19-sub | 0.182 |
| CYP2c9-inh | 0.356 |
| CYP2c9-sub | 0.938 |
| CYP2d6-inh | 0.729 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.792 |
| CYP3a4-sub | 0.128 |
| CL | 4.877 |
| T12 | 0.91 |
| hERG | 0.108 |
| Ames | 0.265 |
| ROA | 0.024 |
| SkinSen | 0.971 |
| Carcinogencity | 0.334 |
| EI | 0.984 |
| Respiratory | 0.925 |
| NR-Aromatase | 0.026 |
| Antiviral | Yes |
| Prediction | 0.700449 |